Relationship between first-trimester serum placental protein-13 and maternal characteristics, placental Doppler studies and pregnancy outcome

References

[1] Baschat AA. Fetal responses to placental insufficiency: an update. Br J Obstet Gynaecol. 2004;111:1031–41.10.1111/j.1471-0528.2004.00273.xSearch in Google Scholar PubMed

[2] Poon LCY, Kametas NA, Pandeva I, Valencia C, Nicolaides KH. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension. 2008;51:1027–33.10.1161/HYPERTENSIONAHA.107.104646Search in Google Scholar PubMed

[3] Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, Espinoza J, et al. First-trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol. 2008;199:122.e1–11.10.1016/j.ajog.2008.01.013Search in Google Scholar PubMed PubMed Central

[4] Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn. 2014;34:618–27.10.1002/pd.4397Search in Google Scholar PubMed

[5] Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8–15.10.1159/000341264Search in Google Scholar PubMed

[6] Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2007;197:35.e1–7.10.1016/j.ajog.2007.02.025Search in Google Scholar PubMed

[7] Than NG, Balogh A, Romero R, Kárpáti E, Erez O, Szilágyi A, et al. Placental protein 13 (PP13) – a placental immunoregulatory galectin protecting pregnancy. Front Immunol. 2014;5:348.10.3389/fimmu.2014.00348Search in Google Scholar PubMed PubMed Central

[8] Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R, et al. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta. 2004;25:608–22.10.1016/j.placenta.2003.12.009Search in Google Scholar PubMed

[9] Kliman HJ, Sammar M, Grimpel YI, Lynch SK, Milano KM, Pick E, et al. Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia. Reprod Sci. 2012;19:16–30.10.1177/1933719111424445Search in Google Scholar PubMed

[10] Nicolaides KH, Bindra R, Turan OM, Chefetz I, Sammar M, Meiri H, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound Obstet Gynecol. 2006;27:13–7.10.1002/uog.2686Search in Google Scholar PubMed

[11] Gonen R, Shahar R, Grimpel YI, Chefetz I, Sammar M, Meiri H, et al. Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study. Br J Obstet Gynaecol. 2008;115:1465–72.10.1111/j.1471-0528.2008.01902.xSearch in Google Scholar PubMed

[12] Spencer K, Cowans NJ, Chefetz I, Tal J, Meiri H. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia. Ultrasound Obstet Gynecol. 2007;29:128–34.10.1002/uog.3876Search in Google Scholar PubMed

[13] Odibo AO, Zhong Y, Goetzinger KR, Odibo L, Bick JL, Bower CR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32:598–602.10.1016/j.placenta.2011.05.006Search in Google Scholar PubMed PubMed Central

[14] Wortelboer EJ, Koster MPH, Cuckle HS, Stoutenbeek PH, Schielen PCJI, Visser GHA. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. Br J Obstet Gynaecol. 2010;117:1384–9.10.1111/j.1471-0528.2010.02690.xSearch in Google Scholar PubMed

[15] Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks. Fetal Diagn Ther. 2011;29:148–54.10.1159/000321694Search in Google Scholar PubMed

[16] Stamatopoulou A, Cowans NJ, Matwejew E, von Kaisenberg C, Spencer K. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes. Hypertens Pregnancy. 2011;30:384–95.10.3109/10641955.2010.484081Search in Google Scholar PubMed

[17] Schwartz N, Sammel MD, Leite R, Parry S. First-trimester placental ultrasound and maternal serum markers as predictors of small-for-gestational-age infants. Am J Obstet Gynecol. 2014;211:253.10.1016/j.ajog.2014.02.033Search in Google Scholar PubMed PubMed Central

[18] Cowans NJ, Spencer K, Meiri H. First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes. Prenat Diagn. 2008;28:121–5.10.1002/pd.1921Search in Google Scholar PubMed

[19] Deurloo KL, Linskens IH, Heymans MW, Heijboer AC, Blankenstein MA, van Vugt JMG. ADAM12s and PP13 as first trimester screening markers for adverse pregnancy outcome. Clin Chem Lab Med. 2013;51:1279–84.10.1515/cclm-2012-0566Search in Google Scholar PubMed

[20] Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One. 2011;6:e21564.10.1371/journal.pone.0021564Search in Google Scholar PubMed PubMed Central

[21] Campbell S, Platt L. The publishing of papers on first-trimester Doppler. Ultrasound Obstet Gynecol. 1999;14:159–60.10.1046/j.1469-0705.1999.14030159.xSearch in Google Scholar

[22] Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–22.10.1067/mob.2000.107928Search in Google Scholar

[23] Vainio M, Kujansuu E, Iso-Mustajärvi M, Mäenpää J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG An Int J Obstet Gynaecol. 2002;109:161–7.10.1111/j.1471-0528.2002.01046.xSearch in Google Scholar

[24] Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia. Prenat Diagn. 2009;29:1103–8.10.1002/pd.2375Search in Google Scholar

[25] Ray JG, Vermeulen MJ, Schull MJ, McDonald S, Redelmeier DA. Metabolic syndrome and the risk of placental dysfunction. J Obstet Gynaecol Can. 2005;27:1095–101.10.1016/S1701-2163(16)30391-7Search in Google Scholar

[26] Ghosh SK, Raheja S, Tuli A, Raghunandan C, Agarwal S. Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2012;161:144–51.10.1016/j.ejogrb.2011.12.031Search in Google Scholar PubMed

[27] Meiri H, Sammar M, Herzog A, Grimpel Y-I, Fihaman G, Cohen A, et al. Prediction of preeclampsia by placental protein 13 and background risk factors and its prevention by aspirin. J Perinat Med. 2014;42:591–601.10.1515/jpm-2013-0298Search in Google Scholar PubMed

[28] Khalil A, Cowans NJ, Spencer K, Goichman S, Meiri H, Harrington K. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound Obstet Gynecol. 2010;35:671–9.10.1002/uog.7559Search in Google Scholar PubMed

[29] Schneuer FJ, Nassar N, Khambalia AZ, Tasevski V, Guilbert C, Ashton AW, et al. First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review. Placenta. 2012;33:735–40.10.1016/j.placenta.2012.05.012Search in Google Scholar PubMed

[30] Huppertz B, Meiri H, Gizurarson S, Osol G, Sammar M. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum Reprod. 2013;19:391–405.10.1093/humupd/dmt003Search in Google Scholar PubMed

[31] Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, et al. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol. 2010;203:383.e1–8.10.1016/j.ajog.2010.06.014Search in Google Scholar PubMed

[32] Cowans NJ, Stamatopoulou A, Khalil A, Spencer K. PP13 as a marker of pre-eclampsia: A two platform comparison study. Placenta. 2011;32(Suppl):S37–41.10.1016/j.placenta.2010.08.014Search in Google Scholar PubMed